For UK MedTech companies
You know digital marketing should work, but regulated healthcare keeps breaking the playbook
Evidence requirements, audience targeting constraints, and channel restrictions mean standard digital approaches routinely underperform or create compliance risk. Most medtech teams are spending without a clear read on what is actually working.
Two minutes. Solva follows up with specific regulated digital strategy options.
- Low engagement rates on generic social media campaigns targeting healthcare professionals.
- Marketing teams struggling to produce compliant content that resonates with a professional audience.
- Over-reliance on sales representatives for initial lead generation, leading to scalability issues.
- Difficulty in tracking and attributing qualified leads to specific digital marketing efforts.
- Inefficient allocation of marketing budgets to underperforming channels.
- Increased workload for compliance and legal teams reviewing non-compliant marketing materials.
- Suboptimal return on marketing investment, leading to higher cost per qualified lead.
- Potential fines or legal costs due to regulatory breaches from non-compliant marketing.
- Damage to brand credibility and trust among healthcare professionals due to inappropriate or non-compliant messaging.
- Negative perception from regulatory bodies (e.g., MHRA, ABPI) leading to increased scrutiny.
No verified UK data available
Source: No verified UK data available
Frequently asked questions
Why does this problem persist?
MedTech marketing is tightly regulated - claims must be evidence-based, targeting must be precise, and channels must be appropriate for a professional audience. Generic digital marketing approaches don't work and can create regulatory risk.
What is the cost of leaving it unaddressed?
No verified UK data available
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.